MedTrace Logo

Adjuvant Colon Cancer w/ ELOXatin®/5 FU Based Regimen: ACCELOX

NCT01310972 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2018-08-10

No results posted yet for this study

Summary

Adjuvant Colon Cancer With ELOXatin®/5 FU Based Regimen: ACCELOX

Conditions

Interventions

OTHER

Registry

Registry

Sponsors & Collaborators

  • King Faisal Specialist Hospital & Research Center

    lead OTHER

Principal Investigators

  • Al Jubran, M.D. · KFSH & RC

Eligibility

Min Age
14 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2007-09-30
Completion
2007-09-30

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01310972 on ClinicalTrials.gov